Skip to main content
. 2014 Nov 1;23(11):894–903. doi: 10.1089/jwh.2014.4730

Table 2.

SWAN Sleep Study Participant Characteristics

    Insomnia SDB
Characteristic All(N=321) Absent(n=273) Present(n=48) Absent(n=257) Present(n=64)
Age, years 52.1 (2.1) 52.1 (2.2) 52.4 (1.9) 52.0 (2.0) 52.8 (2.4)**
Race/ethnicity, n (%)
 African American 112 (34.9) 90 (33.0) 22 (45.8) 85 (33.1) 27 (42.2)
 Caucasian 155 (48.3) 132 (48.3) 23 (47.9) 128 (49.8) 27 (42.2)
 Chinese 54 (16.8) 51 (18.7) 3 (6.3) 44 (17.1) 10 (15.6)
Marital status, n (%)
 Single/widowed/divorced 114 (35.5) 95 (34.8) 19 (39.6) 87 (33.9) 27 (42.2)
 Married/living as married 207 (64.5) 178 (65.2) 29 (60.4) 170 (66.1) 37 (57.8)
Education, n (%)
 Less than college degree 153 (47.7) 128 (46.9) 25 (52.1) 122 (47.5) 31 (48.4)
 College degree or more 168 (52.3) 145 (53.1) 23 (47.9) 135 (52.5) 33 (51.6)
Menopausal status, n (%)
 Pre-/early perimenopause 202 (62.9) 179 (65.6) 23 (47.9) 174 (67.7) 28 (43.8)
 Late perimenopause 60 (18.7) 51 (18.7) 9 (18.8) 41 (16.0) 19 (29.7)*
 Postmenopause/surgical 59 (18.4) 43 (15.8) 16 (33.3)** 42 (16.3) 17 (26.5)
Nocturnal VMS, n (%)
 No/intermittent occurrence 215 (67.0) 192 (70.3) 23 (47.9) 174 (67.7) 41 (54.1)
 At least 3 nights/week 106 (33.0) 81 (29.7) 25 (52.1)** 83 (32.3) 23 (35.9)
Body mass index, kg/m2 30.0 (7.8) 29.2 (7.3) 34.1 (9.4)** 28.4 (6.4) 36.4 (9.5)**
Chronic health conditions, sum 0.8 (1.0) 0.7 (1.0) 1.2 (1.2)** 0.6 (0.9) 1.3 (1.3)**
IDS (sleep items removed), 0–24 2.8 (2.7) 2.3 (2.2) 5.5 (3.3)** 2.6 (2.5) 3.5 (3.2)*
Polysomnographic TST, minutes 381.7 (60.8) 384.5 (58.9) 365.7 (69.2)* 383.1 (61.1) 375.9 (59.8)
Use of sleep-affecting medication, n (%)
 No/intermittent use 245 (76.3) 215 (78.8) 30 (62.5) 196 (76.3) 49 (76.6)
 At least 3 nights/week 76 (23.7) 58 (21.2) 18 (37.5)* 61 (23.7) 15 (23.4)

Data are presented as mean (standard deviation) or n (%), as appropriate. Comparisons of participant characteristics were performed separately according to the presence/absence of insomnia and the presence/absence of SDB using analysis of variance or chi-squared tests, as appropriate. *p<0.05; **p<0.01.

IDS, Inventory of Depressive Symptomatology; SDB, sleep-disordered breathing; TST, total sleep time; VMS, vasomotor symptoms.